U-500 Regular Insulin von Davidson, Mayer B., Navar, Maria D., Echeverry, Diana, Duran, Petra

Volltext

U-500 Regular Insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients von Davidson, Mayer B, Navar, Maria D, Echeverry, Diana, Duran, Petra

Volltext

Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients von BALLANI, Piya, TARN, Michael T, NAVAR, Maria D, DAVIDSON, Mayer B

Volltext

Comparison of the Glycemic Effects of Rosiglitazone and Pioglitazone in Triple Oral Therapy in Type 2 Diabetes von Tran, Michael T, Navar, Maria D, Davidson, Mayer B

Volltext

Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus von Hsia, Stanley H, Navar, Maria D, Duran, Petra, Shaheen, Magda, Davidson, Mayer B

Volltext

Sa1811 IT'S TIME TO INCLUDE CAPSULE ENDOSCOPY TO ASSESS MUCOSAL ACTIVITY AS PART OF THE 'TREAT-TO-TARGET’ STRATEGY IN CROHN'S DISEASE: A REAL-LIFE EXPERIENCE FROM A REFERENCE CENTE... von Gómez, Estanislao J., González, Raquel, Navar, Sofia M., Marturano, María V., Smolarczuk, Astrid, Serra, Belen Conde, Mercado, Johana D., Baron, Pablo E., Pedreira, Silvia C.

Volltext

Telomere length as a biomarker for adiposity changes after a multidisciplinary intervention in overweight/obese adolescents: the EVASYON study von García-Calzón, Sonia, Moleres, Adriana, Marcos, Ascensión, Campoy, Cristina, Moreno, Luis A, Azcona-Sanjulián, M Cristina, Martínez-González, Miguel A, Martínez, J Alfredo, Zalba, Guillermo, Marti, Amelia

Volltext